The effect of deanxit combined with trimebutine maleate in the treatment of patients with functional gastroin-testinal disorders
10.3760/cma.j.issn.1008-6706.2016.01.031
- VernacularTitle:氟哌噻吨美利曲辛联合马来酸曲美布汀治疗功能性胃肠病的疗效观察
- Author:
Kai TANG
;
Tao CHEN
;
Caiping WANG
- Publication Type:Journal Article
- Keywords:
Gastrointestinal diseases;
Flupentixol;
Melitracen;
Trimebutine maleate
- From:
Chinese Journal of Primary Medicine and Pharmacy
2016;(1):114-116,117
- CountryChina
- Language:Chinese
-
Abstract:
Objective To explore the clinical effect of flupentixol and melitracen(deanxit)combined with trimebutine maleate(TMB)in the treatment of patients with functional gastrointestinal disorders(FGID).Methods 135 patients with FGID were selected,and were divided into two groups accorded to the random number method,with 68 cases in the observation group and 67 cases in the control group.The control group was treated with oryzanol and vitamin B6 ,while the observation group was treated with deanxit combine with TMB on the basis of the control group. Main symptoms of postprandial discomfort,early satiety,abdominal pain and burning sensation on the abdomen in the two groups before and after treatment were monitored,adverse reactions of two groups were recorded,and the total efficacy was evaluated after the end of treatment.Results The difference of postprandial discomfort,early satiety, abdominal pain and upper abdominal burning sensation integration between the two groups had no statistically significant before treatment(all P >0.05).After treatment,the postprandial discomfort,early satiety,the abdominal pain and epigastric burning sensation were (4.1 ±1.6)points,(3.4 ±1.1)points,(4.2 ±1.2)points and(4.4 ± 0.7)points in the observation group,which were better than (5.9 ±2.4)points,(5.3 ±1.6 )points,(6.0 ± 1.2)points and(6.1 ±0.5)points in the control group(t =3.057,4.791,5.196,9.681,all P <0.05).The total efficacy was 94.1%(64 /68)in the observation group,which was better than 77.6%(52 /67)in the control group(χ2 =7.603,P <0.05).The difference of adverse reaction rates between the two groups had no statistically significant(P >0.05).Conclusion Deanxit combine with TMB can significantly improve symptoms in patients with FGID,and has a significant effect,thus it is a safe and effective therapy.
